In acute or chronic liver failure, studies have found that Mfn2 can significantly attenuate the symptoms of liver failure, improve the expression of autophagy related proteins, and downregulate the expression of apoptosis-related proteins through the PI3K/Akt/mTOR signaling pathway. Here, MTOR is linked to chronic liver failure.